STOCK TITAN

Guardant Health to Participate in the William Blair 2020 Growth Stock Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Guardant Health will participate in the William Blair Virtual Growth Stock Conference on June 11, 2020. The company's management is set to host a fireside chat at 10:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available in the 'Investors' section of their website. Guardant Health is a leader in precision oncology, focusing on innovative blood tests and analytics to improve cancer care. The firm has introduced liquid biopsy tests such as Guardant360 and GuardantOMNI, which support advanced cancer treatment and early detection efforts.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., May 29, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming William Blair Virtual Growth Stock Conference.

Guardant Health’s management is scheduled for a fireside on Thursday, June 11th at 10:00 a.m. Pacific Time / 12:00 p.m. Central Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.  

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com 

Media Contact:
Anna Czene
press@guardanthealth.com  


FAQ

What date will Guardant Health participate in the William Blair Virtual Growth Stock Conference?

Guardant Health will participate in the William Blair Virtual Growth Stock Conference on June 11, 2020.

What time is Guardant Health's presentation at the conference?

Guardant Health's presentation is scheduled for 10:00 a.m. Pacific Time on June 11, 2020.

Where can I watch Guardant Health's presentation from the conference?

You can watch Guardant Health's presentation live and archived on the 'Investors' section of their official website.

What is the focus of Guardant Health's services?

Guardant Health specializes in precision oncology, utilizing blood tests and analytics to enhance cancer treatment outcomes.

What tests has Guardant Health launched for cancer patients?

Guardant Health has launched the liquid biopsy tests Guardant360 and GuardantOMNI for advanced stage cancer patients.

Guardant Health, Inc.

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

3.76B
117.89M
4.56%
104.62%
8.33%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
PALO ALTO